IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Wockhardt Buys French Pharma Company for $265 Million

1:20 PM MDT | August 9, 2007 | Deepti Ramesh

Wockhardt Ltd. (Mumbai), a pharmaceutical and biotechnology company, has acquired Negma Laboratories (Paris), the fourth-largest pharmaceutical group in France, for $265 million. The acquisition, Wockhardt’s fifth in Europe, means that European sales will account for more than 60% of the company’s total. Negma, with annual sales of $150 million, has a portfolio of 172 patents, and a range of pharma products in various stages of development. “Negma is a unique acquisition for Wockhardt,” says Habil Khorakiwala, chairman of Wockhardt...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa